569
Participants
Start Date
October 29, 2001
Primary Completion Date
September 17, 2004
Study Completion Date
February 10, 2009
erlotinib hydrochloride
150 mg po daily
gemcitabine hydrochloride
1000 mg/m2 IV weekly (Cycle 1 -Day 1, 8, 15, 22, 29, 36, 43 of an 8 week cycle, Cycle 2 and subsequent cycles -Day 1,8 and 15 of a 4 week cycle)
Auckland Hospital, Auckland
Christchurch Hospital, Christchurch
Instituto Nac de Cancerologia, Tlalpan
Institut Jules Bordet, Brussels
Hospital Britanico, Buenos Aires
Instituto de Oncologia Angel H. Roffo, Buenos Aires
Instituto Alexander Fleming, Buenos Aires
Hospital Churruca, Buenos Aires
Confidence Medical Center, San Isidro
Hospital Interzonal De Augudos Euita, Lanús
Institute of Oncology, Randwick
Concord Repatriation General Hospital, Concord
Liverpool Hospital, Liverpool
Clinical County Hospital of Sibiu, Sibiu
Austin and Repatriation Medical Centre, Heidelberg
Frankston Hospital, Frankston
Institutul Oncologic-Universitatea de Medicina, Cluj-Napoca
Royal Adelaide Hospital, Adelaide
Queen Elizabeth Hospital, Woodville
Ashford Cancer Centre, Ashford
Royal Perth Hospital, Perth
St. Spiridon University Hospital, Lasi
Peter MacCallum Cancer Institute, Melbourne
NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York
Beth Israel Medical Center, New York
Staten Island University Hospital, Staten Island
Arena Oncology Associates, Great Neck
Cancer Center at Glens Falls Hospital, Glens Falls
Interlakes Oncology/Hematology PC, Rochester
Haemek Medical Center, Afula
Hematology-Oncology Association of NE Pennsylvania, Dunmore
University of Pennsylvania Cancer Center, Philadelphia
Pennsylvania Oncology Hematology Associates, Philadelphia
Fox Chase Cancer Center, Philadelphia
Sinai Hospital of Baltimore, Baltimore
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
Annapolis Medical Specialists, Annapolis
Hematology & Oncology Associates of Virginia, Mechanicsville
Charleston Hematology-Oncology, P.A., Charleston
Rambam Medical Center, Haifa
Central Georgia Hematology Oncology, P.C., Macon
Oncology-Hematology Group of South Florida, Miami
Oncology & Hematology Associates of West Broward, Tamarac
Florida Cancer Specialists, Fort Myers
Centro Estatal de Cancerologia, Dviango
Sarah Cannon-Minnie Pearl Cancer Center, Nashville
Norton Healthcare Pavilion, Louisville
University Hospitals of Cleveland, Cleveland
Medical Consultants, Muncie
Rabin Medical Center - Beilinson Campus, Petah Tikva
Rabin Medical Center - Golda-Hasharon Campus, Petah Tikva
University of Iowa Hospitals and Clinics, Iowa City
Sheba Medical Center, Tel Litwinsky
Oncology of Wisconsin, Glendale
Hippokration Hospital, Thessaloniki
University of Minnesota Cancer Center, Minneapolis
Northwest Medical Specialists, P.C., Arlington Heights
Midwest Cancer Research Group, Inc., Skokie
Veterans Affairs Medical Center - Hines (Hines Junior VA Hospital), Hines
Oncology/Hematology Associates of Central Illinois, P.C., Peoria
Carle Cancer Center, Urbana
Midwest Oncology Consortium, Kansas City
Tel-Aviv Sourasky Medical Center, Tel Aviv
Metairie
Mary Bird Perkins Cancer Center, Baton Rouge
University Hospital of Heraklion, Iraklion (Heraklion)
Highlands Oncology Group, Springdale
Tyler Hematology Oncology, P.A., Tyler
Arlington Cancer Center, Arlington
Kaplan Hospital, Rehovot
Texas Cancer Care, Fort Worth
Southwest Regional Cancer Center, Austin
Mountain States Tumor Institute, Boise
Arizona Clinical Research Center, Tucson
Kenmar Research Institute, Los Angeles
Century City Hospital, Los Angeles
Policlinico - Cattedra di Ematologia, Palermo
Kaiser Permanente Medical Center/Kaiser Foundation Hospital - San Diego, San Diego
Loma Linda University Cancer Institute, Loma Linda
Alta Bates Comprehensive Cancer Center, Berkeley
Sutter Health West Cancer Research Group, Greenbrae
Western Washington Oncology, Olympia
Southwest Washington Medical Center, Vancouver
National University Hospital, Singapore
Singapore General Hospital, Singapore
National Cancer Centre - Singapore, Singapore
USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles
David Geffen School of Medicine, Los Angeles
Davis, Posteraro, & Wasser, MDs, LLP, Manchester
New Britain General Hospital, New Britain
Eastern Connecticut Hematology and Oncology Associates, Norwich
Hematology Oncology, P.C., Stamford
Ocala Oncology Center, Ocala
Moffitt Clinic at Tampa General Hospital, Tampa
University of Kansas Medical Center, Kansas City
Lucille Parker Markey Cancer Center, University of Kentucky, Lexington
Tulane Cancer Center, New Orleans
Tuft-New England Medical Center, Boston
St. Elizabeth's Medical Center, Boston
Berkshire Physicians and Surgeons, P.C., Pittsfield
Baystate Medical Center, Springfield
New Hampshire Oncology-Hematology PA, Hooksett
St. Barnabas Medical Center, Livingston
Hematology-Oncology Associates, Mount Holly
Cooper Cancer Institute, Voorhees Township
University Hospital - Stony Brook, Stony Brook
Presbyterian Hospital, Charlotte
Mid Dakota Clinic, P.C., Bismarck
Earle A. Chiles Research Institute at Providence Portland Medical Center, Portland
University of Texas - MD Anderson Cancer Center, Houston
Green Mountain Oncology Group, Bennington
Hospital Italiano, Buenos Aires
Newcastle Mater Misericordiae Hospital, Newcastle
Nucleo de Oncologia da Bahia, Bahia
Hospital Santa Rita Irtmandade Santa Casa De Porto Alegre, Porto Alegre
Hospital Israelita Albert Einstein, São Paulo
Cross Cancer Institute, Edmonton
British Columbia Cancer Agency - Centre for the Southern Interior, Kelowna
Penticton Regional Hospital, Penticton
British Columbia Cancer Agency - Fraser Valley Cancer Centre, Surrey
British Columbia Cancer Agency, Victoria
CancerCare Manitoba, Winnipeg
Saint John Regional Hospital, Saint John
Newfoundland Cancer Treatment and Research Foundation, St. John's
Queen Elizabeth II Health Science Centre, Halifax
Royal Victoria Hospital, Barrie, Barrie
Cancer Care Ontario-Hamilton Regional Cancer Centre, Hamilton
Kingston Regional Cancer Centre, Kingston
Cancer Care Ontario-London Regional Cancer Centre, London
Credit Valley Hospital, Mississauga
Southlake Regional Health Centre, Newmarket
Ottawa Regional Cancer Centre, Ottawa
Peterborough Oncology Clinic, Peterborough
Algoma District Medical Group, Sault Ste. Marie
Hotel Dieu Health Sciences Hospital - Niagara, St. Catharines
Toronto East General Hospital, Toronto
Toronto Sunnybrook Regional Cancer Centre, Toronto
Ontario Cancer Institute, Toronto
Toronto General Hospital, Toronto
Saint Joseph's Health Centre - Toronto, Toronto
Maisonneuve-Rosemont Hospital, Montreal
Hopital Du Sacre-Coeur de Montreal, Montreal
L'Hopital Laval, Ste-Foy
Allan Blair Cancer Centre, Regina
Clinica Las Condes, Santiago
Pamela Youde Nethersole Eastern Hospital, Hong Kong
Queen Mary Hospital, Hong Kong
Virchow Klinikum Humboldt Universitaet Berlin, Berlin
Universitaetsklinik und Strahlenklinik - Essen, Essen
Stadtische Kliniken Frankfurt-Hochst, Frankfurt
Tumor Biology Center at the Albert - Ludwigs University, Freiburg im Breisgau
Martin Luther Universitaet, Halle
Medizinische Universitaetsklinik und Poliklinik, Heidelberg
Universitatsklinik, Saarland, Homburg/Saar
University Wurzburg, Würzburg
Theagenio Medical Institute, Thessaloniki
Prince of Wales Hospital, Shatin, New Territories
Great Poland Cancer Center, Poznan
Dolnoslaskie Centrum Oncology, Wroclaw
Institute of Oncology - Bucarest, Bucharest
Queen Elizabeth Hospital, Birmingham
North Middlesex Hospital, Edmonton, London
St. Luke's Cancer Center, Guildford
Princess Royal Hospital, Hull
Saint Bartholomew's Hospital, London
Guy's and St. Thomas' Hospitals NHS Trust, London
Christie Hospital N.H.S. Trust, Manchester
Northern Centre for Cancer Treatment, Newcastle upon Tyne
Royal South Hants Hospital, Southampton
New Cross Hospital, Wolverhampton
Belfast City Hospital Trust, Belfast
Velindre Hospital, Cardiff
Churchill Hospital, Oxford
Lead Sponsor
NCIC Clinical Trials Group
NETWORK